Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Medical Instruments & Supplies
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Covalon Technologies Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Post by TheRock07on Jun 23, 2016 11:40am
91 Views
Post# 24991275

Insider Activity....Buy at $1.53

Insider Activity....Buy at $1.53
Latest 10 SEDI filings (by transaction date) for COV within the last 6 months ?
 Amended Filing
  As of 11:59pm ET June 22nd, 2016
Filing
Date		 Transaction
Date 		 Insider Name Ownership
Type 		 Securities  Nature of transaction Volume or Value  Price 
Jun 17/16 Jun 17/16  Miller, Murray Direct Ownership  Common Shares  10 - Acquisition in the public market 7,000 $1.53
Jun 17/16 Jun 13/16  Miller, Murray Direct Ownership  Options   52 - Expiration of options -230,000 $0.200
Jun 9/16 Jun 8/16  Pedlar, Brian Edward Direct Ownership  Common Shares  36 - Conversion or exchange 322,550 $0.155
Jun 9/16 Jun 8/16  Pedlar, Brian Edward Direct Ownership  Convertible Debentures  36 - Conversion or exchange -$50,000   
Jun 8/16 Jun 3/16  Goldfarb, Stanley Indirect Ownership  Common Shares  36 - Conversion or exchange 1,024,505   
Jun 8/16 Jun 3/16  Goldfarb, Stanley Indirect Ownership  Convertible Debentures  36 - Conversion or exchange -$150,000 $0.155
Jun 8/16 Jun 3/16  Goldfarb, Martin Indirect Ownership  Common Shares  36 - Conversion or exchange 1,024,505   
Jun 8/16 Jun 3/16  Goldfarb, Martin Indirect Ownership  Convertible Debentures  36 - Conversion or exchange -$150,000 $0.155
Jun 8/16 Jun 3/16  Goldfarb, Alonna Indirect Ownership  Common Shares  36 - Conversion or exchange 1,024,505   
Jun 8/16 Jun 3/16  Goldfarb, Alonna Indirect Ownership  Convertible Debentures  36 - Conversion or exchange -$150,000

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities